Screener
CorMedix CRMD Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| TOTAL LIABILITIES | $378,588 | $420,835 |
| COMMITMENTS AND CONTINGENCIES (Note 8) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 91,623 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | - | - |
| Common stock - $0.001 par value: 160,000,000 shares authorized; 78,395,299 and 79,260,667 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 78 | 79 |
| Accumulated other comprehensive income | 2 | 3 |
| Additional paid-in capital | 574,943 | 581,800 |
| Accumulated deficit | (137,974) | (176,575) |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's preferred stock, shares authorized?
- CorMedix (CRMD) reported preferred stock, shares authorized of $2M in Q1 2026.
- How has CorMedix's preferred stock, shares authorized changed year-over-year?
- CorMedix's preferred stock, shares authorized decreased by 0.0% year-over-year, from $2M to $2M.
- What is the long-term trend for CorMedix's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), CorMedix's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $2M to $2M.
Ask your AI about CorMedix's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude